Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
from TTTsv66.https://stkt.co/4xu4swMu | longtermbeliever | investorshub | 07/21/2024 2:21:08 AM |
17M short if great a peer review is | longtermbeliever | investorshub | 07/21/2024 2:09:36 AM |
And your point is? There is no guarantee | kund | investorshub | 07/21/2024 2:07:43 AM |
Just remember.Anything they DO present, the AF of | Rubyred77 | investorshub | 07/21/2024 1:50:03 AM |
i think we may get one or two | longtermbeliever | investorshub | 07/21/2024 12:42:14 AM |
You are a tool. Rooting for $NWBO and | Legend431 | investorshub | 07/21/2024 12:29:22 AM |
they skip 2023 AAIC i don't think they | longtermbeliever | investorshub | 07/21/2024 12:26:07 AM |
JJ---Does Anavex know if and when---if they do | plexrec | investorshub | 07/20/2024 11:51:09 PM |
You can see why the simufilam p2 results | Hoskuld | investorshub | 07/20/2024 7:12:06 PM |
Thanks. Much appreciated. | abew4me | investorshub | 07/20/2024 7:06:22 PM |
https://www.fda.gov/media/168664/download | Hoskuld | investorshub | 07/20/2024 6:40:45 PM |
Do you have a link for this FDA | abew4me | investorshub | 07/20/2024 6:29:50 PM |
Take a look at this recent peer reviewed | Pazzo1212 | investorshub | 07/20/2024 4:57:24 PM |
Does Anavex know if and when the peer | Jonjones325 | investorshub | 07/20/2024 4:16:53 PM |
Because it has not yet been approved and | Steady_T | investorshub | 07/20/2024 4:07:06 PM |
If drug works then why stock is stuck | kund | investorshub | 07/20/2024 4:00:04 PM |
Data and analysis have already been released. | Hoskuld | investorshub | 07/20/2024 3:26:35 PM |
Yep, he is busy backing up imaginary data | kund | investorshub | 07/20/2024 3:01:16 PM |
We have the Safety. Missing needs to release | Reyeton | investorshub | 07/20/2024 2:36:02 PM |
All honest longs here know the answer is | cfoofme | investorshub | 07/20/2024 2:11:08 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...